Gtp Cyclohydrolase I Deficiency
Oncology·MeSH: Mineralocorticoid Excess Syndrome, Apparent
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Gtp Cyclohydrolase I Deficiency?
There are 1 clinical trial targeting Gtp Cyclohydrolase I Deficiency tracked by BioSniper.
What is the prevalence of Gtp Cyclohydrolase I Deficiency?
The estimated prevalence of Gtp Cyclohydrolase I Deficiency is approximately 0.1 per 100,000 population.
Deep-dive into Gtp Cyclohydrolase I Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis